Evidence-based treatment for schizophrenia
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 26 (4) , 939-954
- https://doi.org/10.1016/s0193-953x(03)00070-4
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol on Hostility Among Patients With SchizophreniaPsychiatric Services, 2001
- Fluvoxamine as an Adjunctive Agent in SchizophreniaCNS Drug Reviews, 2001
- A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic SchizophreniaAmerican Journal of Psychiatry, 2001
- Impact of Clozapine on Completed SuicideAmerican Journal of Psychiatry, 2001
- Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic TreatmentAmerican Journal of Psychiatry, 2001
- Management of Negative Symptoms Among Patients With Schizophrenia Attending Multiple-Family GroupsPsychiatric Services, 2000
- A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophreniaPsychological Medicine, 2000
- The effects of neuroleptics on neuropsychological test results of schizophrenicsArchives of Clinical Neuropsychology, 1988